These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 19631677)
1. Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Pitt J; Roth W; Lacor P; Smith AB; Blankenship M; Velasco P; De Felice F; Breslin P; Klein WL Toxicol Appl Pharmacol; 2009 Oct; 240(2):189-97. PubMed ID: 19631677 [TBL] [Abstract][Full Text] [Related]
2. Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies. Abuznait AH; Qosa H; Busnena BA; El Sayed KA; Kaddoumi A ACS Chem Neurosci; 2013 Jun; 4(6):973-82. PubMed ID: 23414128 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies that target pathological assemblies of Abeta. Lambert MP; Velasco PT; Chang L; Viola KL; Fernandez S; Lacor PN; Khuon D; Gong Y; Bigio EH; Shaw P; De Felice FG; Krafft GA; Klein WL J Neurochem; 2007 Jan; 100(1):23-35. PubMed ID: 17116235 [TBL] [Abstract][Full Text] [Related]
5. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. De Felice FG; Vieira MN; Bomfim TR; Decker H; Velasco PT; Lambert MP; Viola KL; Zhao WQ; Ferreira ST; Klein WL Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1971-6. PubMed ID: 19188609 [TBL] [Abstract][Full Text] [Related]
6. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. Lacor PN; Buniel MC; Furlow PW; Clemente AS; Velasco PT; Wood M; Viola KL; Klein WL J Neurosci; 2007 Jan; 27(4):796-807. PubMed ID: 17251419 [TBL] [Abstract][Full Text] [Related]
7. Oleocanthal ameliorates amyloid-β oligomers' toxicity on astrocytes and neuronal cells: In vitro studies. Batarseh YS; Mohamed LA; Al Rihani SB; Mousa YM; Siddique AB; El Sayed KA; Kaddoumi A Neuroscience; 2017 Jun; 352():204-215. PubMed ID: 28392295 [TBL] [Abstract][Full Text] [Related]
10. Protection against β-amyloid-induced synaptic and memory impairments via altering β-amyloid assembly by bis(heptyl)-cognitin. Chang L; Cui W; Yang Y; Xu S; Zhou W; Fu H; Hu S; Mak S; Hu J; Wang Q; Ma VP; Choi TC; Ma ED; Tao L; Pang Y; Rowan MJ; Anwyl R; Han Y; Wang Q Sci Rep; 2015 Jul; 5():10256. PubMed ID: 26194093 [TBL] [Abstract][Full Text] [Related]
11. (-)-Oleocanthal Nutraceuticals for Alzheimer's Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model. Tajmim A; Cuevas-Ocampo AK; Siddique AB; Qusa MH; King JA; Abdelwahed KS; Sonju JJ; El Sayed KA Nutrients; 2021 May; 13(5):. PubMed ID: 34069842 [TBL] [Abstract][Full Text] [Related]
12. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease. Batarseh YS; Kaddoumi A J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486 [TBL] [Abstract][Full Text] [Related]
13. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model. Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065 [TBL] [Abstract][Full Text] [Related]
14. Drebrin in Alzheimer's Disease. Ishizuka Y; Hanamura K Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase mediates the decrease in drebrin cluster density induced by amyloid beta oligomers. Ishizuka Y; Shimizu H; Takagi E; Kato M; Yamagata H; Mikuni M; Shirao T Neurochem Int; 2014 Oct; 76():114-21. PubMed ID: 25058791 [TBL] [Abstract][Full Text] [Related]
16. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers. Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339 [TBL] [Abstract][Full Text] [Related]
17. Why Alzheimer's is a disease of memory: the attack on synapses by A beta oligomers (ADDLs). Viola KL; Velasco PT; Klein WL J Nutr Health Aging; 2008 Jan; 12(1):51S-7S. PubMed ID: 18165846 [TBL] [Abstract][Full Text] [Related]
18. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475 [TBL] [Abstract][Full Text] [Related]
19. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease. Shi XD; Sun K; Hu R; Liu XY; Hu QM; Sun XY; Yao B; Sun N; Hao JR; Wei P; Han Y; Gao C J Neurosci; 2016 Nov; 36(47):11959-11973. PubMed ID: 27881781 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices. Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]